Kontakt

Dr. Sandra Hauser

Wissenschaftliche Mitarbeiterin
Radiopharmazeutische und Chemische Biologie
s.hauserAthzdr.de
Tel.: +49 351 260 4046

Prof. Dr. Jens Pietzsch

Abteilungsleiter
Radiopharmazeutische und Chemische Biologie
j.pietzschAthzdr.de
Tel.: +49 351 260 2622

Tissue Regeneration and Inflammation Imaging

This group aims at developing and validating molecular imaging techniques to study, particularly, inflammatory and extracellular matrix-modifying processes. Our research consists of three lines. Firstly, we focus on the development and validation of targeted compounds for detection of early biomarkers of pathology using PET, SPECT, optical imaging or MRI. Secondly, selected substances are tested for their suitability as therapeutic agents. Specific examples of such compounds are selective cyclooxygenase-2 inhibitors for diagnostic targeting and therapeutic modulation of inflammatory processes, particularly, associated with biomaterial approaches for bone and soft tissue regeneration as well as with solid tumors. Selective transglutaminase-2 inhibitors address matrix-modifying processes in tissue regeneration or tumor progression. Thirdly, we study animal models for pathologies such as critical bone defects as well as selected tumors with a pronounced pro-inflammatory and matrix-associated microenvironment to improve our understanding of the disease process.

 

Key publications

Projects (multicenter)

  • Functional Biomaterials for Controlling Healing Processes in Bone and Skin - From Material Science to Clinical Application; DFG, Transregio Collaborative Research Centre TRR67; subproject B5.

Research initiatives

  • MATRESIST: Matrix-Associated Therapy Resistance

Further literature on our hypotheses and approaches


Kontakt

Dr. Sandra Hauser

Wissenschaftliche Mitarbeiterin
Radiopharmazeutische und Chemische Biologie
s.hauserAthzdr.de
Tel.: +49 351 260 4046

Prof. Dr. Jens Pietzsch

Abteilungsleiter
Radiopharmazeutische und Chemische Biologie
j.pietzschAthzdr.de
Tel.: +49 351 260 2622